MARIA CECILIA BUNIEL, M.D.
Medical Practice at Sam Jackson Park Rd, Portland, OR
License number
Oregon MED-PHYS-LIC-53190
Category
Medical Practice
Type
Otolaryngology
Address
Address
2
3181 SW Sam Jackson Park Rd, Portland, OR 97239
2321 W 17Th St APT DOWN, Cleveland, OH 44113
2321 W 17Th St APT DOWN, Cleveland, OH 44113
Phone
(503) 494-8211
(216) 407-9893
(216) 407-9893
Personal information
See more information about MARIA CECILIA BUNIEL at radaris.comName
Address
Phone
3306 Library Ave, Cleveland, OH 44109
11205 Clifton Blvd, Cleveland, OH 44102
2906 Bridge Ave, Cleveland, OH 44113
1586 Winchester Ave, Lakewood, OH 44107
3306 Library Ave, Cleveland, OH 44109
Professional information
See more information about MARIA CECILIA BUNIEL at trustoria.com
Dr. Maria C Buniel, Portland OR - MD (Doctor of Medicine)
Dr. Maria C Buniel, Portland OR - MD (Doctor of Medicine)
Specialties:
Ear, Nose, and Throat
Age:
46
Address:
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8211 (Phone), (503) 346-6997 (Fax)
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone)
OREGON HEALTH AND SCIENCE UNIVERSITY HOSPITAL
3181 SW Sam Jackson Park Rd SUITE L340, Portland 97239
(503) 494-8211 (Phone), (503) 494-7037 (Fax)
LEGACY CLINIC AT GOOD SAMARITAN HOSPITAL
1015 NW 22Nd Ave, Portland 97210
(503) 413-8258 (Phone), (503) 413-7626 (Fax)
(503) 494-8211 (Phone), (503) 346-6997 (Fax)
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW Sam Jackson Park Rd, Portland 97239
(503) 494-8311 (Phone)
OREGON HEALTH AND SCIENCE UNIVERSITY HOSPITAL
3181 SW Sam Jackson Park Rd SUITE L340, Portland 97239
(503) 494-8211 (Phone), (503) 494-7037 (Fax)
LEGACY CLINIC AT GOOD SAMARITAN HOSPITAL
1015 NW 22Nd Ave, Portland 97210
(503) 413-8258 (Phone), (503) 413-7626 (Fax)
Languages:
English
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 2010
Case Western Reserve University School of Medicine
Graduated: 2010
Maria Cecilia Buniel, Portland OR
Maria Cecilia Buniel, Portland OR
Work:
Oregon Health & Science University
3181 SW Sam Jackson Park Rd, Portland, OR 97239
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Education:
Case Western Reserve University(2010)
Compositions Comprising Addl Receptors, Related Compositions, And Related Methods
Compositions Comprising Addl Receptors, Related Compositions, And Related Methods
US Patent:
2008030, Dec 11, 2008
Filed:
May 16, 2005
Appl. No.:
11/569122
Inventors:
Pascale N. Lacor - Chicago IL, US
Kirsten L. Viola - Chicago IL, US
Mary P. Lambert - Glenview IL, US
Lei Chang - Westmont IL, US
Pauline T. Velasco - Wilmette IL, US
Eileen H. Bigio - Riverside IL, US
Maria C. Buniel - Cleveland OH, US
Sara J. Fernandez - Chicago IL, US
Jasna Jerecic - San Francisco CA, US
Susan Catalano - Hayward CA, US
Todd Pray - San Mateo CA, US
Ray Lowe - San Francisco CA, US
Grant A. Krafft - Glenview IL, US
William L. Klein - Winnetka IL, US
Kirsten L. Viola - Chicago IL, US
Mary P. Lambert - Glenview IL, US
Lei Chang - Westmont IL, US
Pauline T. Velasco - Wilmette IL, US
Eileen H. Bigio - Riverside IL, US
Maria C. Buniel - Cleveland OH, US
Sara J. Fernandez - Chicago IL, US
Jasna Jerecic - San Francisco CA, US
Susan Catalano - Hayward CA, US
Todd Pray - San Mateo CA, US
Ray Lowe - San Francisco CA, US
Grant A. Krafft - Glenview IL, US
William L. Klein - Winnetka IL, US
International Classification:
A61K 31/498, G01N 33/567, A61P 25/28
US Classification:
514249, 435 721
Abstract:
Disclosed and claimed herein are compositions comprising ADDL receptors, related compositions, and related methods. ADDL receptors are typically, but perhaps not exclusively, localized at the post-synaptic density (PSD) of neuronal cells. Related compositions include, but are not limited to, compounds that affect, positively or negatively, ADDL binding to neuronal cells, either via one or more receptors localized at the post-synaptic density (PSD) or otherwise. Related methods include, but are not limited to, procedures to screen for compounds that affect, either positively or negatively, ADDL binding to neuronal cells, either via one or more receptors localized at the post-synaptic density (PSD) or otherwise. Other related methods include, but are not limited to, prevention and treatment of ADDL-related diseases, such as Alzheimer's disease, mild cognitive impairment, Down's syndrome, and the like, using compositions that inhibit, block, or otherwise interfere with ADDL binding to one or more receptors localized at the post-synaptic density of neuronal cells.